BioSpace News Archive

Depth of Anesthesia Monitoring Devices Market Size US$ 400 Mn by 2030

The depth of anesthesia monitoring devices market is anticipated to register a modest CAGR of ~5% during the forecast period.

July 27, 2022
·
12 min read
Enteric Disease Testing Market Size US$ 3.8 Bn in 2022

The global enteric disease testing market was valued at US$ 3.8 Bn in 2022 and is anticipated to expand at a CAGR of 3.3% from 2022 to 2023.

July 27, 2022
·
6 min read
Hemostasis Diagnostics Market Growth at a CAGR of 8.5% from 2022 to 2030

According to the report, the global hemostasis diagnostics market was valued at US$ 2.3 Bn in 2022 and is anticipated to expand at a CAGR of 8.5% from 2022 to 2030.

July 27, 2022
·
9 min read
Laparoscopy Devices Market Valued at US$ 8.5 Billion in 2022

The global laparoscopy devices market was valued at US$ 8.5 Bn in 2022 and is anticipated to expand at a CAGR of 6.5% from 2022 to 2030.

July 27, 2022
·
10 min read
Stool Secretory Immunoglobulin A [SIgA] Market Size, Growth, Report 2030

The global stool secretory immunoglobulin A (SIgA) market was valued at ~US$ 27 Mn in 2022. It is anticipated to expand at a CAGR of ~3% from 2022 to 2030.

July 27, 2022
·
9 min read
Tissue Processing Systems Market Size, Growth, Report 2022 to 2030

The global tissue processing systems market is expected to expand at a moderate CAGR of ~5% during the forecast period.

July 27, 2022
·
10 min read
Vascular Access Devices Market Expanding Growth 5.8% from 2022 to 2030

The global vascular access devices market was valued at US$ 6,077.2 Mn in 2022 and is anticipated to expand at a CAGR of 5.8% from 2022 to 2030.

July 27, 2022
·
8 min read
Krabbe Disease Market Growth 2022-2030: Raising Awareness of Krabbe Illness is a Demand Factor of the Industry

Forecast to 2030,’ thoroughly examines the Krabbe Disease industry to provide essential data & information for the targeted readers.

July 27, 2022
·
5 min read
European Medicines Agency’s Emergency Task Force Has Initiated the Review of Veru’s Sabizabulin Treatment for Hospitalized COVID-19 Patients for Emergency Use in European Union Countries

Veru Inc. (NASDAQ: VERU), today announced that the European Medicines Agency’s (EMA) Emergency Task Force (ETF) has informed the Company that it has initiated the review of sabizabulin for the treatment of hospitalized COVID-19 patients at high risk for Acute Respiratory Distress Syndrome (ARDS).

July 27, 2022
·
10 min read
Biotech Beach

Cymbiotika Launches Reformulated Activated Charcoal to Support Digestive System

Cymbiotika, a leading nutritional supplement brand known for creating pure, clinically backed supplements, today announced the relaunch of its Activated Charcoal.

July 27, 2022
·
2 min read